.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
QuintilesIMS
Federal Trade Commission
Queensland Health
Johnson and Johnson
Colorcon
Baxter
AstraZeneca
Chinese Patent Office
McKinsey

Generated: November 19, 2017

DrugPatentWatch Database Preview

BUTABARBITAL Drug Profile

« Back to Dashboard

What is the patent landscape for Butabarbital, and when can generic versions of Butabarbital launch?

Butabarbital is a drug marketed by Bundy, Solvay, Whiteworth Town Plsn, Teva, Sandoz, Watson Labs, and Wockhardt. and is included in sixteen NDAs.

The generic ingredient in BUTABARBITAL is butabarbital sodium. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the butabarbital sodium profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bundy
BUTABARBITAL
butabarbital sodium
TABLET;ORAL085550-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Whiteworth Town Plsn
BUTABARBITAL SODIUM
butabarbital sodium
TABLET;ORAL083337-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
BUTABARBITAL SODIUM
butabarbital sodium
TABLET;ORAL088631-001May 1, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Wockhardt
BUTABARBITAL SODIUM
butabarbital sodium
ELIXIR;ORAL085383-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
BUTABARBITAL SODIUM
butabarbital sodium
TABLET;ORAL085938-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Solvay
BUTABARBITAL SODIUM
butabarbital sodium
TABLET;ORAL083898-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Solvay
BUTABARBITAL SODIUM
butabarbital sodium
TABLET;ORAL083896-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Solvay
BUTABARBITAL SODIUM
butabarbital sodium
TABLET;ORAL083606-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Whiteworth Town Plsn
BUTABARBITAL SODIUM
butabarbital sodium
TABLET;ORAL083325-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
BUTABARBITAL SODIUM
butabarbital sodium
TABLET;ORAL085934-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Mallinckrodt
Fuji
Johnson and Johnson
US Department of Justice
Healthtrust
Covington
Merck
Farmers Insurance
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot